alpha 1d Adrenoceptor signaling is required for stimulus induced locomotor activity.
alpha 1 Adrenergic receptors mediate a variety of physiological responses and have been well studied in the cardiovascular and peripheral nervous system. However, their role in the central nervous system remains ill defined because of the lack of highly specific ligands to the alpha1 receptor subtypes. Here, we have employed gene targeting to elucidate the role of alpha 1d receptors in vivo. In addition to disrupting function, the insertion of the lacZ gene into the alpha 1d receptor locus enabled the specific identification of cells expressing the alpha 1d gene. These cells are localized in the cortex, hippocampus, olfactory bulb, dorsal geniculate and ventral posterolateral nuclei of the thalamus. Behaviorally, the alpha 1d(-/-) mice show normal locomotor activity during the subjective day, or resting phase of their cycle. However, during subjective night, or active phase, wheel-running activity is significantly reduced in mutant mice. Furthermore, these mice show a reduction in exploratory rearing behavior in a novel cage environment. Lastly, alpha 1d(-/-) mice show reduced hyperlocomotion after acute amphetamine administration. Together, these data reveal the functional importance of alpha 1d adrenoceptors in mediating a variety of stimulus-induced changes in locomotor behaviors. While the sensitivity of noradrenergic neurons to environmental stimuli has been well documented, our data demonstrate that at least some of these post-synaptic responses are mediated by alpha 1d adrenergic receptors.
Sadalge
A
A
Department of Pharmacology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Coughlin
L
L
Fu
H
H
Wang
B
B
Valladares
O
O
Valentino
R
R
Blendy
J A
JA
D000483:Alleles; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D001921:Brain / Q000502:physiology; D001931:Brain Mapping; D002678:Chimera / Q000235:genetics; D002940:Circadian Rhythm; D003042:Cocaine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D004777:Environment; D005106:Exploratory Behavior / Q000187:drug effects; D005260:Female; D018390:Gene Targeting; D007763:Lac Operon; D008124:Locomotion; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009043:Motor Activity / Q000187:drug effects / Q000235:genetics*; D016254:Mutagenesis, Insertional; D009419:Nerve Tissue Proteins / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D012333:RNA, Messenger / Q000032:analysis; D011930:Reaction Time / Q000235:genetics; D018340:Receptors, Adrenergic, alpha-1 / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D012399:Rotation
C547720:Adra1d protein, mouse; D009419:Nerve Tissue Proteins; D012333:RNA, Messenger; D018340:Receptors, Adrenergic, alpha-1; D003042:Cocaine; D003913:Dextroamphetamine